UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 194

Sortiert nach

Cancer Cell-specific Transfection of hCas9 Gene Using Ad5F35 Vector

Anticancer research, 2021-08, Vol.41 (8), p.3731-3740

2021

Volltextzugriff (PDF)

Immune activation during the implantation phase causes preeclampsia-like symptoms via the CD40-CD40 ligand pathway in pregnant mice

Hypertension research, 2016-06, Vol.39 (6), p.407-414

2016

Volltextzugriff (PDF)

Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells

Pharmaceutics, 2021-01, Vol.13 (1), p.57

2021

Volltextzugriff (PDF)

A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity

Molecular therapy. Oncolytics, 2016, Vol.3 (C), p.16022-16022, Article 16022

2016

Volltextzugriff (PDF)

Adenoviral Expression of p53 Represses Telomerase Activity through Down-Regulation of Human Telomerase Reverse Transcriptase Transcription

Clinical cancer research, 2000-04, Vol.6 (4), p.1239-1247

2000

Volltextzugriff (PDF)

Antitumor effect of chondroitin sulfate-coated ternary granulocyte macrophage-colony-stimulating factor plasmid complex for ovarian cancer

The journal of gene medicine, 2012-02, Vol.14 (2), p.120-127

2012

Volltextzugriff (PDF)

Oncolytic plasmid: A novel strategy for tumor immuno-gene therapy

Oncology letters, 2012-02, Vol.3 (2), p.387-390

2012

Volltextzugriff (PDF)

Abstract 590: Preclinical biosafety test of oncolytic adenovirus-infected carrier cell for Phase I study

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.590-590

Hamada, Katsuyuki

2010

Volltextzugriff (PDF)

DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice

Biomaterials, 2010-04, Vol.31 (10), p.2912-2918

2010

Volltextzugriff (PDF)

Improved Gene Transfer into Renal Carcinoma Cells Using Adenovirus Vector Containing RGD Motif

Anticancer research, 2009-08, Vol.29 (8), p.2997-3001

2009

Volltextzugriff (PDF)

Intravenous injection of irradiated tumor cell vaccine carrying oncolytic adenovirus suppressed the growth of multiple lung tumors in a mouse squamous cell carcinoma model

The journal of gene medicine, 2011-06, Vol.13 (6), p.353-361

2011

Volltextzugriff (PDF)

Midkine Promoter-Based Conditionally Replicative Adenovirus for Targeting Midkine-Expressing Human Bladder Cancer Model

Urology (Ridgewood, N.J.), 2007-11, Vol.70 (5), p.1009-1013

2007

Volltextzugriff (PDF)

Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter

Molecular therapy. Methods & clinical development, 2014-01, Vol.1 (C), p.14019-14019, Article 14019

2014

Volltextzugriff (PDF)

420. Improvement of Antitumor Activity in Intraperitoneal Ovarian Cancer Model by a Noble Cloned Carrier Cell Infected with Oncolytic Adenovirus

Molecular therapy, 2016-05, Vol.24, p.S166-S167

2016

Volltextzugriff (PDF)

Enantioselective synthesis of β-amino acid derivatives via nickel-promoted regioselective carboxylation of ynamides and rhodium-catalyzed asymmetric hydrogenation

Organic & biomolecular chemistry, 2016-01, Vol.14 (42), p.10080-10089

2016

Volltextzugriff (PDF)

A Cox-2 Promoter-Based Replication-Selective Adenoviral Vector to Target the Cox-2-Expressing Human Bladder Cancer Cells

Clinical cancer research, 2004-07, Vol.10 (13), p.4342-4348

2004

Volltextzugriff (PDF)

437. Biosafety After the Injection of Carrier Cells Infected With Oncolytic Adenovirus

Molecular therapy, 2015-05, Vol.23, p.S173-S173

2015

Volltextzugriff (PDF)

Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy

Oncology reports, 2004-07, Vol.12 (1), p.73

2004

Volltextzugriff (PDF)

141. Ovarian Cancer-Specific Gene Therapy by Oncolytic Adenovirus

Molecular therapy, 2006-05, Vol.13 (S1), p.S56-S56

Hamada, Katsuyuki

2006

Volltextzugriff (PDF)

Enantioselective synthesis of β-amino acid derivatives via nickel-promoted regioselective carboxylation of ynamides and rhodium-catalyzed asymmetric hydrogenationElectronic supplementary information (ESI) available. See DOI: 10.1039/c6ob01234e

2016-10

Volltextzugriff (PDF)

Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies

The journal of gene medicine, 2019-02, Vol.21 (2-3), p.e3064-n/a

2019

Volltextzugriff (PDF)

Etodolac, a Selective Cyclooxygenase-2 Inhibitor, Induces Upregulation of E-Cadherin and Has Antitumor Effect on Human Bladder Cancer Cells In Vitro and In Vivo

Urology (Ridgewood, N.J.), 2008, Vol.71 (1), p.156-160

2008

Volltextzugriff (PDF)

989. IAI.3B Promoter Is Ovarian Cancer Specific

Molecular therapy, 2004-05, Vol.9 (S1), p.S379-S379

Hamada, Katsuyuki

2004

Volltextzugriff (PDF)

Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients

Cancer, 1995-07, Vol.76 (1), p.72-78

1995

Volltextzugriff (PDF)

631. Novel Polymer-Coated Stealth Oncolytic Measles Virus Overcame Immune Suppression and Induced Stronger Antitumor Activity

Molecular therapy, 2015-05, Vol.23, p.S251-S251

2015

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(169)

Publikationsform

Sprache

Englisch
(172)
Japanisch
(68)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer Cell-specific Transfection of hCas9 Gene Using Ad5F35 Vector

Immune activation during the implantation phase causes preeclampsia-like symptoms via the CD40-CD40 ligand pathway in pregnant mice

Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells

A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity

Adenoviral Expression of p53 Represses Telomerase Activity through Down-Regulation of Human Telomerase Reverse Transcriptase Transcription

Antitumor effect of chondroitin sulfate-coated ternary granulocyte macrophage-colony-stimulating factor plasmid complex for ovarian cancer

Oncolytic plasmid: A novel strategy for tumor immuno-gene therapy

Abstract 590: Preclinical biosafety test of oncolytic adenovirus-infected carrier cell for Phase I study

DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice

Improved Gene Transfer into Renal Carcinoma Cells Using Adenovirus Vector Containing RGD Motif

Intravenous injection of irradiated tumor cell vaccine carrying oncolytic adenovirus suppressed the growth of multiple lung tumors in a mouse squamous cell carcinoma model

Midkine Promoter-Based Conditionally Replicative Adenovirus for Targeting Midkine-Expressing Human Bladder Cancer Model

Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter

420. Improvement of Antitumor Activity in Intraperitoneal Ovarian Cancer Model by a Noble Cloned Carrier Cell Infected with Oncolytic Adenovirus

Enantioselective synthesis of β-amino acid derivatives via nickel-promoted regioselective carboxylation of ynamides and rhodium-catalyzed asymmetric hydrogenation

A Cox-2 Promoter-Based Replication-Selective Adenoviral Vector to Target the Cox-2-Expressing Human Bladder Cancer Cells

437. Biosafety After the Injection of Carrier Cells Infected With Oncolytic Adenovirus

Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy

141. Ovarian Cancer-Specific Gene Therapy by Oncolytic Adenovirus

Enantioselective synthesis of β-amino acid derivatives via nickel-promoted regioselective carboxylation of ynamides and rhodium-catalyzed asymmetric hydrogenationElectronic supplementary information (ESI) available. See DOI: 10.1039/c6ob01234e

Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies

Etodolac, a Selective Cyclooxygenase-2 Inhibitor, Induces Upregulation of E-Cadherin and Has Antitumor Effect on Human Bladder Cancer Cells In Vitro and In Vivo

989. IAI.3B Promoter Is Ovarian Cancer Specific

Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients

631. Novel Polymer-Coated Stealth Oncolytic Measles Virus Overcame Immune Suppression and Induced Stronger Antitumor Activity

Suchergebnisse filtern